Replies to post #116985 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

The estimated worldwide cost of Dementia in 2018 is around 1 Trillion Dollars.


This does not even begin to explain the value of a successful treatment.


A frenzy for our shares is soon to begin. I will think of Biogen loving, Ship of Fools singing Corey" Where's the Lab" Renauer for those who sell early.
You have been "Renaured"..brutal

[plexrec]

I'll second the motion for a "sticky" here---great post (summary) nobrainer--excellent job !!!!!

[attilathehunt]

Phenomenal job nobrainer!!!

Please make this a sticky!!

[jimmy667]

Bravo! Agree it should be stickies at the top.

[kld2]

Well-done.

To make it even better, striving for balance, I suggest you include a "Concerns" section.

[sliceanddice59]

One thing I might add in regard to the upcoming Rett trial. Rett's is a rare disease. Another rare disease is Duchenne muscular dystrophy. Last year the FDA approved Sarepta's drug eteplirsen for that disease after a 12 patient trial which did not have a placebo arm. Vocal parents who could see firsthand the beneficial effects of the drug had a lot to do with that.

[wildcard235]

This should be stickied because it is far more valuable than all the current stickied notes combined.

[baltimorebullet]

Well done sir.

[Boopka]

Nobrainer, I read your synopsis of AVXL back in 2017 and you did a great job. This is my first time posting here and I have a question for you hoping that you did some research on this topic.

It appears that a drug that has strong antioxidant properties might have the ability to partially/reverse the devastating effects of Alzheimer's. Have you done any research to lead you to the conclusion that A2-73 has strong antioxidant properties? If so, can you please let me know how you arrived at this conclusion? Many thanks in advance!